Anhui Wanbang Pharmaceutical Technology

Anhui Wanbang Pharmaceutical Technology is a China-based Contract Research Organization (CRO) providing integrated services for pharmaceutical research and development. The company specializes in bioequivalence (BE) studies, clinical trial management, and pharmaceutical technology transfer, primarily serving the generic drug industry. With a focus on regulatory compliance and high-quality clinical data, Wanbang supports clients through Phase I to IV clinical trials and pharmacokinetics research. The firm is headquartered in Hefei and is listed on the Shenzhen Stock Exchange, positioning itself as a key player in the domestic Chinese pharmaceutical outsourcing market. Its service portfolio covers the entire drug development process from pharmaceutical research to clinical evaluation.